SIEBERT FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SIEBERT FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $94.20M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $83.90M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $71.51M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $50.10M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $67.51M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $54.87M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $42.78M | Mar 10, 2021 |
| FY2018 | Dec 31, 2018 | $6.49M | Mar 29, 2019 |
| FY2018 | Sep 30, 2018 | $7.88M | Mar 29, 2019 |
| FY2018 | Jun 30, 2018 | $7.49M | Mar 29, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $7.83M | May 10, 2024 |
| FY2023 | Dec 31, 2022 | ($1.99M) | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $5.06M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $2.98M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $3.24M | Mar 10, 2021 |
| FY2018 | Dec 31, 2018 | $5.35M | Mar 29, 2019 |
| FY2018 | Sep 30, 2018 | $3.12M | Mar 29, 2019 |
| FY2018 | Jun 30, 2018 | $1.80M | Mar 29, 2019 |
| FY2018 | Mar 31, 2018 | $1.69M | Mar 29, 2019 |
| FY2018 | Dec 31, 2017 | $733.0K | Mar 29, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $17.47M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $18.13M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $440.0K | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $6.58M | Mar 29, 2023 |
| FY2017 | Dec 31, 2017 | $2.31M | Apr 13, 2018 |
| FY2017 | Dec 31, 2016 | ($5.58M) | Apr 13, 2018 |
| FY2016 | Dec 31, 2015 | ($3.09M) | Apr 6, 2017 |
| FY2016 | Dec 31, 2014 | ($6.62M) | Apr 6, 2017 |
| FY2015 | Dec 31, 2013 | ($5.83M) | Mar 30, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.24M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $10.05M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($4.80M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | ($24.62M) | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $5.54M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $96.72M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $24.35M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $4.87M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.45M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($3.26M) | Apr 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $552.0K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $223.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $223.0K | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $284.0K | May 10, 2024 |
| FY2021 | Dec 31, 2021 | $296.0K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $13.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.01M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $277.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $417.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $38.0K | Apr 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $759.04M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $519.67M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $801.80M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $728.05M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $1.40B | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $1.37B | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $538.07M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $18.18M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $6.03M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $3.82M | Apr 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $669.88M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $434.58M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $731.09M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $678.13M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $1.35B | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $1.34B | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $504.93M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $1.00M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $813.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $1.56M | Apr 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.16M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $84.09M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $69.72M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $48.95M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $49.26M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $37.99M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $33.14M | Mar 10, 2021 |
| FY2020 | Dec 31, 2018 | $17.17M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $5.21M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.25M | Mar 29, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.32M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $2.32M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.99M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $1.99M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $1.99M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $1.99M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $1.99M | Mar 10, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.22M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $40.09M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $26.81M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $18.98M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $20.97M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $15.91M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $12.93M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $9.26M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($2.70M) | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | ($4.86M) | Apr 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.41M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $32.63M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $5.74M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $23.67M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | $3.76M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | $3.63M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $4.67M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $7.23M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.77M | Mar 29, 2019 |
| FY2018 | Dec 31, 2016 | $2.73M | Mar 29, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | Mar 30, 2026 |
| FY2024 | Dec 31, 2024 | $4.23M | Apr 1, 2025 |
| FY2023 | Dec 31, 2023 | $4.31M | May 10, 2024 |
| FY2021 | Dec 31, 2021 | $3.66M | Mar 30, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 10, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 29, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 10, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 29, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Apr 13, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.44M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 40.12M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 39.58M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 32.51M | May 10, 2024 |
| FY2022 | Dec 31, 2021 | 32.40M | Mar 29, 2023 |
| FY2021 | Dec 31, 2020 | 30.95M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 30.46M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 27.16M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | 27.16M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 22.09M | Apr 13, 2018 |